Brief: Richard Abbe Reports 5.1% Stake In PharmaCyte Biotech Inc As Of Oct 27
Nov 4 (Reuters) - PharmaCyte Biotech Inc PMCB.O :
* RICHARD ABBE REPORTS 5.1% STAKE IN PHARMACYTE BIOTECH INC
AS OF
OCTOBER 27 - SEC FILING
* RICHARD ABBE SAYS PURCHASED PHARMACYTE BIOTECH INC'S
SECURITIES
BASED ON BELIEF THAT SUCH SECURITIES, WHEN PURCHASED, WERE
"UNDERVALUED"
Source text for Eikon: ID:
Further company coverage: PMCB.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Pharmacyte Biotech
See all newsBrief: Pharmacyte Biotech Inc - Increases Stake In Tnf Pharmaceuticals By $3 Million
Brief: PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys
Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech
Brief: Pharmacyte Biotech Announces Final Results Of Tender Offer